Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 992 

    Article Cited by others

NEW HORIZON

Reversal of liver fibrosis

Ismail Mona H, Pinzani Massimo

Year : 2009| Volume: 15| Issue : 1 | Page no: 72-79

   This article has been cited by
 
1 Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model
Alvi Yasmin, Daniel P. Regan, Lawrence B. Schook, Ron C. Gaba, Kyle M. Schachtschneider
Biochimie. 2021; 182: 73
[Pubmed]  [Google Scholar] [DOI]
2 Quantification of non-alcoholic fatty liver disease progression in 3D liver microtissues using impedance spectroscopy
Jaehwan Ahn, Jun-Ho Ahn, Seokjoo Yoon, Mi-Young Son, Sungbo Cho, Jung-Hwa Oh
Biomaterials. 2021; 268: 120599
[Pubmed]  [Google Scholar] [DOI]
3 Effect of Curcumol on NOD-Like Receptor Thermoprotein Domain 3 Inflammasomes in Liver Fibrosis of Mice
Yang Zheng, Lei Wang, Jia-hui Wang, Lu-lu Liu, Tie-jian Zhao
Chinese Journal of Integrative Medicine. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 The role of osteoprotegerin (OPG) in fibrosis: its potential as a biomarker and/or biological target for the treatment of fibrotic diseases
Habibie Habibie, Adhyatmika Adhyatmika, Dedmer Schaafsma, Barbro N. Melgert
Pharmacology & Therapeutics. 2021; 228: 107941
[Pubmed]  [Google Scholar] [DOI]
5 Rapid Two-Photon Fluorescence Imaging of Monoamine Oxidase B for Diagnosis of Early-Stage Liver Fibrosis in Mice
Nannan Fan, Chuanchen Wu, Yongqing Zhou, Xin Wang, Ping Li, Zhenzhen Liu, Bo Tang
Analytical Chemistry. 2021; 93(18): 7110
[Pubmed]  [Google Scholar] [DOI]
6 Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway
Xiaohe Li, Hailong Li, Shanshan Zhang, Ruotong Zhang, Jinhe Li, Yiying Wei, Cheng Yang, Fubo Zhang, Honggang Zhou
Journal of Cellular and Molecular Medicine. 2021;
[Pubmed]  [Google Scholar] [DOI]
7 Microscope-Based Automated Quantification of Liver Fibrosis in Mice Using a Deep Learning Algorithm
Yuval Ramot, Ameya Deshpande, Virginia Morello, Paolo Michieli, Tehila Shlomov, Abraham Nyska
Toxicologic Pathology. 2021; 49(5): 1126
[Pubmed]  [Google Scholar] [DOI]
8 Serum N-glycan fingerprint nomogram predicts liver fibrosis: a multicenter study
Chenjun Huang, Lijuan Liu, Hao Wang, Meng Fang, Huijuan Feng, Ya Li, Mengmeng Wang, Lin Tong, Xiao Xiao, Ziyi Wang, Xuewen Xu, Yutong He, Chunfang Gao
Clinical Chemistry and Laboratory Medicine (CCLM). 2021; 59(6): 1087
[Pubmed]  [Google Scholar] [DOI]
9 Cellular and Molecular Mechanism of Liver Fibrosis: A Critical Insight
Gnyana Ranjan Parida, Gurudutta Pattnaik, Amulyaratna Behera
Research Journal of Pharmacy and Technology. 2021; : 6147
[Pubmed]  [Google Scholar] [DOI]
10 cis-4-[18F]fluoro-L-proline Molecular Imaging Experimental Liver Fibrosis
Qi Cao, Xin Lu, Babak Behnam Azad, Martin Pomper, Mark Smith, Jiang He, Liya Pi, Bin Ren, Zhekang Ying, Babak Saboury Sichani, Michael Morris, Vasken Dilsizian
Frontiers in Molecular Biosciences. 2020; 7
[Pubmed]  [Google Scholar] [DOI]
11 Genomics of Human Fibrotic Diseases: Disordered Wound Healing Response
Rivka C. Stone, Vivien Chen, Jamie Burgess, Sukhmani Pannu, Marjana Tomic-Canic
International Journal of Molecular Sciences. 2020; 21(22): 8590
[Pubmed]  [Google Scholar] [DOI]
12 Systems biology predicts that fibrosis in tuberculous granulomas may arise through macrophage-to-myofibroblast transformation
Stephanie Evans, J. Russell Butler, Joshua T. Mattila, Denise E. Kirschner, Qing Nie
PLOS Computational Biology. 2020; 16(12): e1008520
[Pubmed]  [Google Scholar] [DOI]
13 Effect of hepato-toxins in the acceleration of hepatic fibrosis in hepatitis B mice
Suchithra Poilil Surendran, Reju George Thomas, Myeong Ju Moon, Rayoung Park, Doo Hyun Kim, Kyun Hwan Kim, Yong Yeon Jeong, Wenyu Lin
PLOS ONE. 2020; 15(5): e0232619
[Pubmed]  [Google Scholar] [DOI]
14 Human umbilical cord-derived mesenchymal stem cells conditioned medium ameliorates CCl4-induced liver fibrosis through regulation of expression and activity of liver lysyl oxidase
Mahdi Bahmani, Nasrin Ziamajidi, Mohammad Hashemnia, Roghayeh Abbasalipourkabir
Toxin Reviews. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
15 Sennoside A prevents liver fibrosis by binding DNMT1 and suppressing DNMT1-mediated PTEN hypermethylation in HSC activation and proliferation
Hong Zhu, Changsheng He, Huizi Zhao, Wenjuan Jiang, Songbing Xu, Jun Li, Taotao Ma, Cheng Huang
The FASEB Journal. 2020; 34(11): 14558
[Pubmed]  [Google Scholar] [DOI]
16 A bilirubin-conjugated chitosan nanotheranostics system as a platform for reactive oxygen species stimuli-responsive hepatic fibrosis therapy
Suchithra Poilil Surendran, Reju George Thomas, Myeong Ju Moon, Rayoung Park, Jae Hyuk Lee, Yong Yeon Jeong
Acta Biomaterialia. 2020; 116: 356
[Pubmed]  [Google Scholar] [DOI]
17 Effect of curcumin supplementation on disease severity in patients with liver cirrhosis: A randomized controlled trial
Masoud Nouri-Vaskeh, Aida Malek Mahdavi, Hossein Afshan, Leila Alizadeh, Mohammad Zarei
Phytotherapy Research. 2020; 34(6): 1446
[Pubmed]  [Google Scholar] [DOI]
18 Candidate rejuvenating factor GDF11 and tissue fibrosis: friend or foe?
Jan Frohlich, Manlio Vinciguerra
GeroScience. 2020; 42(6): 1475
[Pubmed]  [Google Scholar] [DOI]
19 Nicotinamide riboside protects against liver fibrosis induced by CCl4 via regulating the acetylation of Smads signaling pathway
Rui Jiang, Yujia Zhou, Sufan Wang, Nengzhi Pang, Yuanling Huang, Mingtong Ye, Ting Wan, Yun Qiu, Lei Pei, Xuye Jiang, Yufeng Huang, Hainan Yang, Wenhua Ling, Xufeng Li, Zhenfeng Zhang, Lili Yang
Life Sciences. 2019; 225: 20
[Pubmed]  [Google Scholar] [DOI]
20 Cas9-nickaseľmediated genome editing corrects hereditary tyrosinemia in rats
Yanjiao Shao, Liren Wang, Nana Guo, Shengfei Wang, Lei Yang, Yajing Li, Mingsong Wang, Shuming Yin, Honghui Han, Li Zeng, Ludi Zhang, Lijian Hui, Qiurong Ding, Jiqin Zhang, Hongquan Geng, Mingyao Liu, Dali Li
Journal of Biological Chemistry. 2018; 293(18): 6883
[Pubmed]  [Google Scholar] [DOI]
21 Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution
Shao-Jung Hsu, Ming-Hung Tsai, Ching-Chih Chang, Yu-Hsin Hsieh, Hui-Chun Huang, Fa-Yauh Lee, Chiao-Ling Chuang, Ming-Chih Hou, Shou-Dong Lee
Clinical Science. 2018; 132(6): 669
[Pubmed]  [Google Scholar] [DOI]
22 Utility of Serum miR-122, Liver Enzymes, and Hepatic Histopathology in Response to Hepatotoxicants in Sprague-Dawley Rats
Erica E. Carroll, Danielle L. Ippolito, Matthew G. Permenter, B. Claire McDyre, Christine E. Baer, David M. Kumsher, Molly H. Boyle, Valerie T. DiVito, John A. Lewis, Jason M. Koontz
Toxicologic Pathology. 2018; 46(7): 835
[Pubmed]  [Google Scholar] [DOI]
23 Immuno-biological comparison of hepatic stellate cells in a reverted and activated state
Mehdi Najar, Hussein Fayyad-Kazan, Wissam H. Faour, Adil El Taghdouini, Gordana Raicevic, Leo A. van Grunsven, Mustapha Najimi, Etienne Sokal, Laurence Lagneaux
Biomedicine & Pharmacotherapy. 2018; 98: 52
[Pubmed]  [Google Scholar] [DOI]
24 Evaluation of liver fibrosis with a monoexponential model of intravoxel incoherent motion magnetic resonance imaging
Cuiyun Chen, Fangfang Fu, Jing Zhang, Fangfang Guo, Meiyun Wang, Shaocheng Zhu, Dapeng Shi, Yuwei Tian
Oncotarget. 2018; 9(37): 24619
[Pubmed]  [Google Scholar] [DOI]
25 Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling
Misako Sato-Matsubara, Tsutomu Matsubara, Atsuko Daikoku, Yoshinori Okina, Lisa Longato, Krista Rombouts, Le Thi Thanh Thuy, Jun Adachi, Takeshi Tomonaga, Kazuo Ikeda, Katsutoshi Yoshizato, Massimo Pinzani, Norifumi Kawada
Journal of Biological Chemistry. 2017; 292(46): 18961
[Pubmed]  [Google Scholar] [DOI]
26 Establishment of a liver fibrosis model in cynomolgus monkeys
Ke Ding,Man-Rong Liu,Jianmin Li,Ke Huang,Yi Liang,Xiaobin Shang,Jiong Chen,Jian Mu,Huimei Liu
Experimental and Toxicologic Pathology. 2014; 66(5-6): 257
[Pubmed]  [Google Scholar] [DOI]
27 Effect of antioxidant therapy on hepatic fibrosis and liver iron concentrations in ╬▓-thalassemia major patients
Elalfy, M.S. and Adly, A.A.M. and Attia, A.A.M. and Ibrahim, F.A. and Mohammed, A.S. and Sayed, A.M.
Hemoglobin. 2013; 37(3): 257-276
[Pubmed]  [Google Scholar]
28 Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis
Zeisberg, M. and Kalluri, R.
American Journal of Physiology - Cell Physiology. 2013; 304(3): C216-C225
[Pubmed]  [Google Scholar]
29 Inhibition of hepatic fibrosis with artificial microRNA using ultrasound and cationic liposome-bearing microbubbles
D Yang,Y-H Gao,K-B Tan,Z-X Zuo,W-X Yang,X Hua,P-J Li,Y Zhang,G Wang
Gene Therapy. 2013;
[Pubmed]  [Google Scholar] [DOI]
30 Effect of Antioxidant Therapy on Hepatic Fibrosis and Liver Iron Concentrations in ▀-Thalassemia Major Patients
Mohsen S. Elalfy,Amira A.M. Adly,Atef A.M. Attia,Fatma A. Ibrahim,Amer S. Mohammed,Abdelbasset M. Sayed
Hemoglobin. 2013; 37(3): 257
[Pubmed]  [Google Scholar] [DOI]
31 Prospective non-invasive follow-up of liver fibrosis in patients with chronic hepatitis C
Crisan, D. and Radu, C. and Grigorescu, M.D. and Lupsor, M. and Feier, D. and Grigorescu, M.
Journal of Gastrointestinal and Liver Diseases. 2012; 21(4): 375-382
[Pubmed]  [Google Scholar]
32 Antifibrotic potential of a selective COX-2 inhibitor (celecoxib) on liver fibrosis in rats
Mona M. Ftahy, Noha S. Abdl Latif, Essam F. Alalkamy, Fatma A. El-Batrawi, Ahmad H. Galal, Hany M. Khatab
Comparative Clinical Pathology. 2012;
[HTML Full text]  [Google Scholar] [DOI]
33 Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice
Wang, R.Q., Nan, Y.M., Wu, W.J., Kong, L.B., Han, F., Zhao, S.X., Kong, L., Yu, J.
Lipids in Health and Disease. 2011; 10(art 31)
[Pubmed]  [Google Scholar]
34 Nonalcoholic fatty liver disease and type 2 diabetes mellitus: The hidden epidemic
Ismail, M.H.
American Journal of the Medical Sciences. 2011; 341(6): 485-492
[Pubmed]  [Google Scholar]
35 Pharmacological therapy of nonalcoholic steatohepatitis
Hojo, M. and Watanabe, S.
Hepatology Research. 2011; 41(3): 209-216
[Pubmed]  [Google Scholar]
36 Correlative research between leptin and TGF-╬▓1 and the recovery on CCl4 induced hepatic fibrosis in rats
Li, H. and Li, J. and Huang, C. and Huang, Y. and Zhang, L. and Li, Z.-T. and Zhang, S.-P. and Cheng, J.
Chinese Pharmacological Bulletin. 2011; 27(4): 473-477
[Pubmed]  [Google Scholar]
37 KangXian FuFang I inhibits acetaldehyde-stimulated extracellular matrix synthesis and cytokine secretion in cultured hepatic stellate cells
Lin, H., Huang, Y.-H., Li, Y.-L., Fu, B.-Y., Wang, B.-Y.
World Chinese Journal of Digestology. 2011; 19(17): 1826-1829
[Pubmed]  [Google Scholar]
38 Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice
Rong Wang,Yue Nan,Wen Wu,Ling Kong,Fang Han,Su Zhao,Li Kong,Jun Yu
Lipids in Health and Disease. 2011; 10(1): 31
[Pubmed]  [Google Scholar] [DOI]
39 Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: The Hidden Epidemic
Mona H. Ismail
The American Journal of the Medical Sciences. 2011; 341(6): 485
[Pubmed]  [Google Scholar] [DOI]
40 Pharmacological therapy of nonalcoholic steatohepatitis
Mariko Hojo,Sumio Watanabe
Hepatology Research. 2011; 41(3): 209
[Pubmed]  [Google Scholar] [DOI]
41 Advances in hepatic stellate cell-targeted treatment of hepatic fibrosis with bone marrow-derived mesenchymal stem cells
Hu, M.-D. and Guo, G.-H.
World Chinese Journal of Digestology. 2010; 18(24): 2558-2562
[Pubmed]  [Google Scholar]
42 Liver fibrosis: A dynamic and potentially reversible process
Povero, D. and Busletta, C. and Novo, E. and Di Bonzo, L.V. and Cannito, S. and Paternostro, C. and Parola, M.
Histology and Histopathology. 2010; 25(8): 1075-1091
[Pubmed]  [Google Scholar]

 

Read this article